text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 102767-28-2 | Product Number: L0234

Levetiracetam


Purity: >98.0%(HPLC)(N)
Synonyms:
  • (S)-2-(2-Oxo-1-pyrrolidinyl)butyramide
Documents:
1G
₹6,700
Contact Us Contact Us ≥20 
5G
₹9,800
Contact Us 1   ≥20 

*Upon orders receipt, Hyderabad stocks will be dispatched on the same day & Chennai stocks will be dispatched in 3-6 working days.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*Change currency to place order in USD.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.


Product Number L0234
Purity / Analysis Method >98.0%(HPLC)(N)
Molecular Formula / Molecular Weight C__8H__1__4N__2O__2 = 170.21  
Physical State (20 deg.C) Solid
CAS RN 102767-28-2
Reaxys Registry Number 8407472
PubChem Substance ID 125307963
SDBS (AIST Spectral DB) 52977
MDL Number

MFCD03265610

Specifications
Appearance White to Almost white powder to crystal
Purity(HPLC) min. 98.0 area%
Purity(with Total Nitrogen) min. 98.0 %
Melting point 116.0 to 120.0 °C
Specific rotation [a]20/D -86.0 to -90.0 deg(C=1, Acetone)
Properties (reference)
Melting Point 118 °C
Specific Rotation -88° (C=1,Acetone)
Solubility (soluble in) Acetone
GHS
Pictogram Pictogram
Signal Word Warning
Hazard Statements H302 : Harmful if swallowed.
H319 : Causes serious eye irritation.
Precautionary Statements P501 : Dispose of contents/ container to an approved waste disposal plant.
P270 : Do not eat, drink or smoke when using this product.
P264 : Wash skin thoroughly after handling.
P280 : Wear eye protection/ face protection.
P337 + P313 : If eye irritation persists: Get medical advice/ attention.
P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth.
Related Laws:
RTECS# UX9656166
Transport Information:
Application
Pharmacology study

References

  • Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy
    • W. Loscher, D. Honack, C. Rundfeldt, J. Pharmacol. Exp. Ther. 1998, 284, 474.
  • The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes


PubMed Literature


TCIMAIL
Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number is entered
Analytical Charts
Please enter Lot Number Incorrect Lot Number is entered

The requested analytical chart is not available. Sorry for the inconvenience.

Other Documents